Advertisement
Singapore markets closed
  • Straits Times Index

    3,301.78
    +4.23 (+0.13%)
     
  • S&P 500

    5,473.23
    +41.63 (+0.77%)
     
  • Dow

    38,778.10
    +188.94 (+0.49%)
     
  • Nasdaq

    17,857.02
    +168.14 (+0.95%)
     
  • Bitcoin USD

    65,296.24
    -532.26 (-0.81%)
     
  • CMC Crypto 200

    1,354.42
    -34.98 (-2.52%)
     
  • FTSE 100

    8,164.83
    +22.68 (+0.28%)
     
  • Gold

    2,324.40
    -4.60 (-0.20%)
     
  • Crude Oil

    80.27
    -0.06 (-0.07%)
     
  • 10-Yr Bond

    4.2790
    +0.0660 (+1.57%)
     
  • Nikkei

    38,482.11
    +379.67 (+1.00%)
     
  • Hang Seng

    17,915.55
    -20.57 (-0.11%)
     
  • FTSE Bursa Malaysia

    1,606.13
    -1.19 (-0.07%)
     
  • Jakarta Composite Index

    6,734.83
    -96.73 (-1.42%)
     
  • PSE Index

    6,368.80
    -14.90 (-0.23%)
     

Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.

Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.

Gilead Sciences stock was climbing Friday on hopes that it would get into the obesity-drug game. GLP-1s, the technical name for the popular obesity drugs, has been one of the biggest drivers of pharmaceutical stocks in recent months. Which may be why Gilead stock has gained 2.8% to $64.55 in afternoon trading Friday after Jefferies released a note late Thursday night.